Roles of Empagliflozin in Diabetic Cardiomyopathy: A Review

Current Vascular Pharmacology · Published 2025-01-28 · DOI 10.2174/0115701611319744250116092707

Authors being retrieved — see the publisher record. https://doi.org/10.2174/0115701611319744250116092707

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

Irisin upregulation as a contributory mechanism for the therapeutic benefits of SGLT-2 inhibitors · Pharmacology and Therapeutics · 2026 · Cites or is cited by this article
Is the Cardiovascular Risk Increased in Patients with Isolated SystolicHypertension and Anemia? · Current Vascular Pharmacology · 2026 · Same journal
Comparison of Clinical Outcomes between Newly Diagnosed and Pre-Existing Diabetes Mellitus Patients after Acute Coronary Syndrome · Current Vascular Pharmacology · 2025 · Same journal
Clinical Predictors of Warfarin Response Among Patients with Atrial Fibrillation: Evidence from the Middle Eastern JoFib Study · Current Vascular Pharmacology · 2025 · Same journal
Glucagon-like Peptide-1 Receptor Agonists: Additional Improvement of Erectile Dysfunction in Type 2 Diabetes · Current Vascular Pharmacology · 2025 · Same journal
Postprandial Triglycerides and Residual Cardiovascular Risk: RethinkingLipid-Lowering Strategies · Current Vascular Pharmacology · 2026 · Same journal
PCSK9: Its Role in Lipid Metabolism and as a Novel Target for the Treatment of Metabolic Kidney Disease · Current Vascular Pharmacology · 2025 · Same journal
Advances in Drug-Eluting Angioplasty Balloon Coatings, Clinical Implications and Future Directions: A Mini Review · Current Vascular Pharmacology · 2025 · Same journal
Cardiovascular Risks of Electronic Cigarettes: Mechanisms, Evidence, and Research Gaps · Current Vascular Pharmacology · 2026 · Same journal
Significant Stagnancy in the Search and Use of New Antiarrhythmic Agents With Some Recent Beams of Hope · Current Vascular Pharmacology · 2025 · Same journal